1
|
Yagihashi T, Inoue T, Shiba S, Yamano A, Minagawa Y, Omura M, Inoue K, Nagata H. Impact of delivery time factor on treatment time and plan quality in tomotherapy. Sci Rep 2023; 13:12207. [PMID: 37500671 PMCID: PMC10374581 DOI: 10.1038/s41598-023-39047-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Accepted: 07/19/2023] [Indexed: 07/29/2023] Open
Abstract
Delivery time factor (DTF) is a new parameter introduced by the RayStation treatment planning system for tomotherapy treatment planning. This study investigated the effects of this factor on various tomotherapy plans. Twenty-five patients with cancer (head and neck, 6; lung, 9; prostate, 10) were enrolled in this study. Helical tomotherapy plans with a field width of 2.5 cm, pitch of 0.287, and DTF of 2.0 were created. All the initial plans were recalculated by changing the DTF parameter from 1.0 to 3.0 in increments of 0.1. Then, DTF's impact on delivery efficiency and plan quality was evaluated. Treatment time and modulation factor increased monotonically with increasing DTF. Increasing the DTF by 0.1 increased the treatment time and modulation factor by almost 10%. This relationship was similar for all treatment sites. Conformity index (CI), homogeneity index, and organ at risk doses were improved compared to plans with a DTF of 1.0, except for the CI in the lung cancer case. However, the improvement in most indices ceased at a certain DTF; nevertheless, treatment time continued to increase following an increase in DTF. DTF is a critical parameter for improving the quality of tomotherapy plans.
Collapse
Affiliation(s)
- Takayuki Yagihashi
- Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
- Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashiogu, Arakawa-ku, Tokyo, 116-8551, Japan
| | - Tatsuya Inoue
- Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
- Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
| | - Shintaro Shiba
- Department of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
| | - Akihiro Yamano
- Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
| | - Yumiko Minagawa
- Department of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
| | - Motoko Omura
- Department of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
| | - Kazumasa Inoue
- Graduate School of Human Health Sciences, Tokyo Metropolitan University, 7-2-10 Higashiogu, Arakawa-ku, Tokyo, 116-8551, Japan
| | - Hironori Nagata
- Department of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan
| |
Collapse
|
2
|
Kim C, Han MC, Lee YK, Shin HB, Kim H, Kim JS. Comprehensive clinical evaluation of TomoEQA for patient-specific pre-treatment quality assurance in helical tomotherapy. Radiat Oncol 2022; 17:177. [DOI: 10.1186/s13014-022-02151-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Accepted: 10/24/2022] [Indexed: 11/09/2022] Open
Abstract
Abstract
Background
Based on a previous study on the feasibility of TomoEQA, an exit detector-based patient-specific pre-treatment quality assurance (QA) method for helical tomotherapy, an in-depth clinical evaluation was conducted.
Methods
Data of one hundred patients were analyzed to evaluate the clinical usefulness of TomoEQA for patient-specific pre-treatment QA in comparison with the conventional phantom-based method. Additional investigations were also performed under unusual measurement conditions to validate the off-axis region. In addition to the clinical evaluation of TomoEQA, a statistical analysis was conducted to determine the plan parameters that affect the pass/failure results of pre-treatment QA.
Results
The average and standard deviations of the gamma passing rate and point dose error for TomoEQA were comparable to those of the conventional QA method. For TomoEQA, the average values of the gamma passing rate and point dose error were 96.32% (standard deviation (1 sigma) = 3.94; 95% confidence interval (CI), 95.55 to 97.09) and − 1.12% (standard deviation (1 sigma) = 1.04; CI, − 1.32 to − 0.92), respectively. For the conventional QA method, the average values of the gamma passing rate and point dose error were 95.95% (standard deviation (1 sigma) = 4.35; 95% confidence interval (CI), 95.10 to 96.80) and − 1.20% (standard deviation (1 sigma) = 1.61; CI, − 1.52 to − 0.88), respectively. Further experiments on the off-axis region demonstrated that TomoEQA can provide accurate results for 3D dose analysis, which is inherently difficult in the conventional QA method. Through a statistical analysis based on the results of TomoEQA, it was validated that the total fraction (Total Fx), monitor units, beam-on-time, leaf-of-time below 100 ms, and planning target volume diameter were statistically significant for the pass/failure of the pre-treatment QA results.
Conclusions
TomoEQA is a clinically beneficial alternative to the conventional phantom-based QA method.
Collapse
|
3
|
Barlaz Us S, Ataol AS, Ergun G. Impact of different fixed dental prostheses on radiation dose in helical tomotherapy as measured with metal oxide semiconductor field-effect transistor dosimetry. Oral Surg Oral Med Oral Pathol Oral Radiol 2022; 133:716-724. [PMID: 35248513 DOI: 10.1016/j.oooo.2022.01.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 01/03/2022] [Accepted: 01/08/2022] [Indexed: 11/27/2022]
Abstract
OBJECTIVE This ex vivo study evaluated the effects of different fixed dental prostheses and protective materials on scattered radiation during radiation therapy (RT). STUDY DESIGN Natural teeth (group NT) and 4 types of prostheses (group BL: bilayer lithium disilicate glass-ceramic; group MZ: monolithic zirconia ceramic; group BZ: bilayer zirconia-based all ceramic; and group BM: bilayer metal-ceramic restorations) were examined in maxillary and mandibular arch phantoms. All groups were divided into 3 subgroups: (1) without protective material over the prostheses; (2) protected with a soft acrylic night guard; and (3) protected with polyvinylsiloxane putty. All groups were irradiated with helical RT at 2 Gy and 6 MV photon energy. Doses were measured internally and externally 3 times on each phantom. Results were significant at P < .05. RESULTS No statistically significant differences in doses were found between groups NT and BL in either phantom, but these groups were different from the others. The differences between groups BZ and MZ were insignificant. Doses in group BM were significantly larger than all other groups. No significant differences existed between doses with and without protective material. CONCLUSIONS Doses increased significantly due to scattered radiation from the prostheses with increasing material density. Protective materials had no significant effect on dose.
Collapse
Affiliation(s)
- Songul Barlaz Us
- Faculty of Medicine, Department of Radiation Oncology, Mersin University, Mersin, Turkey.
| | | | - Gulfem Ergun
- Faculty of Dentistry, Department of Prosthodontics, Gazi University, Ankara, Turkey.
| |
Collapse
|
4
|
Kouris P, Moutsatsos A, Pappas EP, Beli I, Pantelakos P, Karaiskos P, Pantelis E. Assessing the dose rate delivery of helical TomoTherapy prostate and head & neck treatments. Biomed Phys Eng Express 2021; 8. [PMID: 34755680 DOI: 10.1088/2057-1976/ac37cb] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Accepted: 11/09/2021] [Indexed: 11/11/2022]
Abstract
The dose rate distributions delivered to 55 prostate and head & neck (H&N) cancer patients treated with a helical TomoTherapy (HT) system were resolved and assessed with regard to pitch and field width defined during treatment planning. Statistical analysis of the studied cases showed that the median treatment delivery time was 4.4 min and 6.3 min for the prostate and H&N cases, respectively. Dose rate volume histogram data for the studied cases showed that the 25% and 12% of the volume of the planning target volumes of the prostate and H&N cases are irradiated with a dose rate of greater or equal to 1 Gy min-1. Quartile dose rate (QDR) data confirmed that in HT, where the target is irradiated in slices, most of the dose is delivered to each voxel of the target when it travels within the beam. Analysis of the planning data from all cases showed that this lasts for 68 s (median value). QDRs results showed that using the 2.5 cm field width, 75% of the prescribed dose is delivered to target voxels with a median dose rate of at least 3.2 Gy min-1and 4.5 Gy min-1, for the prostate and H&N cases, respectively. Systematically higher dose rates were observed for the H&N cases due to the shallower depths of the lesions in this anatomical site. Delivered dose rates were also found to increase with field width and pitch setting, due to the higher output of the system which, in general, results in accordingly decreased total treatment time. The biological effect of the dose rate findings of this work needs to be further investigated using in-vitro studies and clinical treatment data.
Collapse
Affiliation(s)
- P Kouris
- Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece
| | - A Moutsatsos
- Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece.,Radiotherapy and Radiosurgery Department, Latropolis Clinic, 54-56 Ethnikis Antistaseos, 15231 Athens, Greece
| | - E P Pappas
- Radiotherapy and Radiosurgery Department, Latropolis Clinic, 54-56 Ethnikis Antistaseos, 15231 Athens, Greece
| | - I Beli
- Radiotherapy and Radiosurgery Department, Latropolis Clinic, 54-56 Ethnikis Antistaseos, 15231 Athens, Greece
| | - P Pantelakos
- Radiotherapy and Radiosurgery Department, Latropolis Clinic, 54-56 Ethnikis Antistaseos, 15231 Athens, Greece
| | - P Karaiskos
- Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece
| | - E Pantelis
- Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece.,Radiotherapy and Radiosurgery Department, Latropolis Clinic, 54-56 Ethnikis Antistaseos, 15231 Athens, Greece
| |
Collapse
|
5
|
Total body irradiation of bone marrow transplant using helical TomoTherapy with a focus on the quality of dose contribution at junction target volumes. Strahlenther Onkol 2021; 197:722-729. [PMID: 33852037 DOI: 10.1007/s00066-021-01769-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Accepted: 03/16/2021] [Indexed: 12/23/2022]
Abstract
PURPOSE Total body irradiation (TBI) can be safely delivered on TomoTherapy (Accuray, Sunnyvale, CA, USA) in both pediatric and adult patients with proper imaging and planning despite the length constraint of 135 cm. To overcome this limitation, two CT (Computed Tomography) scans (CT1& CT2) are taken in patients above 135 cm in height. Adequate junction dose coverage is important in TBI. Presently, there is no clinical report with a focus on the quality of dose distribution at the CT junction in view of the guidelines on quality of coverage from the RTOG. Hence, our main objectives were to evaluate the dose distribution and quality of coverage at the junction in 16 patients who received TBI using TomoTherapy. METHODS PTV(upper) and PTV(lower) along with a junction were created on CT1 and CT2, respectively. Subsequently, the 10 cm junction in the thigh region was divided into five target volumes of 2 cm thickness with dose prescription ranging from 10 to 90% to deliver a total dose equal to 100% when fused. RESULTS The D50 was equal to the prescribed dose in most of the cases ranging from 99.5 to 104% for PTV(upper), 100-103% for PTV(lower), and 99.5-108% for junctional PTVs (1PTV, 2PTV, 3PTV, 4PTV, and 5PTV). The average D95 doses from PTV(upper) and PTV(lower) were 97 ± 1.4% and 96.7 ± 1.08%, respectively. The average D95 doses for 1PTV, 2PTV, 3PTV, 4PTV, and 5PTV were 96.1 ± 1.88%, 91.6 ± 1.82%, 87.3 ± 1.5%, 91.6 ± 1.4%, and 96.2 ± 1.5% respectively. QRTOG values ranged between 0.85 and 1.05 and were in concordance with RTOG guidelines. CONCLUSION Since junction-based planning was required for most TBI patients, it is essential to evaluate the quality of dose coverage in the junction for better TBI plans.
Collapse
|
6
|
Muthuselvi CA, Bijina TK, Pichandi A. Evaluation of Optimal Combination of Planning Parameters (Field Width, Pitch, and Modulation Factor) in Helical Tomotherapy for Bilateral Breast Cancer. J Med Phys 2021; 45:234-239. [PMID: 33953499 PMCID: PMC8074714 DOI: 10.4103/jmp.jmp_31_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Revised: 11/23/2020] [Accepted: 12/03/2020] [Indexed: 11/05/2022] Open
Abstract
Aim: The aim of the study was to find the most balanced plan with an optimal combination of planning parameters in helical tomotherapy (HT) for bilateral breast irradiation by evaluating dosimetric indices and time factors. In particular, we investigated the best combination of field width (FW), pitch, and modulation factor (MF). Materials and Methods: A total of 90 plans (18 plans for each patient) was created in this study, with different combination of planning parameters (FW: 2.5 cm [F1] and 5 cm [F2]; pitch: 0.215 [P1], 0.287 [P2], and 0.43 [P3]; and MF: 2.0 [M1], 2.5 [M2], and 3.0 [M3]). Plans were analyzed using several dosimetric indices: homogeneity index, conformity index, dose near minimum D98%, dose near maximum D2%, and the coverage by D95% of the target. Organ at risk (OAR) doses were evaluated by mean dose, V5Gy and V25Gy for the heart and mean dose V5Gy and V20Gy for both the lungs. Treatment time was also reported for all plans. Results: Reducing FW from 5 cm to 2.5 cm increased the treatment time by 40%–50% and improved homogeneity of the target. Tightening the pitch value from 0.43 to 0.215 improved target as well as OAR doses without increasing the treatment time. Increasing MF from 2 to 3 improved all the dosimetric indices and also increased treatment time. Conclusions: On the basis of our analysis, a plan with FW 5 cm, pitch 0.215, and MF 2.5 can be considered as an optimal combination of planning parameters for bilateral breast irradiation in HT technique.
Collapse
Affiliation(s)
- C A Muthuselvi
- Department of Radiotherapy, Health Care Global Enterprises Ltd., Bengaluru, Karnataka, India
| | - T K Bijina
- Department of Radiotherapy, Health Care Global Enterprises Ltd., Bengaluru, Karnataka, India
| | - A Pichandi
- Department of Radiotherapy, Health Care Global Enterprises Ltd., Bengaluru, Karnataka, India
| |
Collapse
|
7
|
Chang KH, Lee YH, Park BH, Han MC, Kim J, Kim H, Cho MS, Kang H, Lee H, Kim DW, Park K, Cho J, Kim YB, Kim JS, Hong CS. Statistical Analysis of Treatment Planning Parameters for Prediction of Delivery Quality Assurance Failure for Helical Tomotherapy. Technol Cancer Res Treat 2020; 19:1533033820979692. [PMID: 33302821 PMCID: PMC7734483 DOI: 10.1177/1533033820979692] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Purpose: This study aimed to investigate the parameters with a significant impact on delivery quality assurance (DQA) failure and analyze the planning parameters as possible predictors of DQA failure for helical tomotherapy. Methods: In total, 212 patients who passed or failed DQA measurements were retrospectively included in this study. Brain (n = 43), head and neck (n = 37), spinal (n = 12), prostate (n = 36), rectal (n = 36), pelvis (n = 13), cranial spinal irradiation and a treatment field including lymph nodes (n = 24), and other types of cancer (n = 11) were selected. The correlation between DQA results and treatment planning parameters were analyzed using logistic regression analysis. Receiver operating characteristic (ROC) curves, areas under the curves (AUCs), and the Classification and Regression Tree (CART) algorithm were used to analyze treatment planning parameters as possible predictors for DQA failure. Results: The AUC for leaf open time (LOT) was 0.70, and its cut-off point was approximately 30%. The ROC curve for the predicted probability calculated when the multivariate variable model was applied showed an AUC of 0.815. We confirmed that total monitor units, total dose, and LOT were significant predictors for DQA failure using the CART. Conclusions: The probability of DQA failure was higher when the percentage of LOT below 100 ms was higher than 30%. The percentage of LOT below 100 ms should be considered in the treatment planning process. The findings from this study may assist in the prediction of DQA failure in the future.
Collapse
Affiliation(s)
- Kyung Hwan Chang
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Young Hyun Lee
- Eretec Inc. 401, Simin-daero, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea
| | - Byung Hun Park
- Eretec Inc. 401, Simin-daero, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea
| | - Min Cheol Han
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Jihun Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Hojin Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Min-Seok Cho
- Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea
| | - Hyokyeong Kang
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Ho Lee
- Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Dong Wook Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Kwangwoo Park
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Jaeho Cho
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Yong Bae Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Jin Sung Kim
- Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Chae-Seon Hong
- Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea
| |
Collapse
|
8
|
Comparative evaluation of treatment plan quality for a prototype biology-guided radiotherapy system in the treatment of nasopharyngeal carcinoma. Med Dosim 2020; 46:171-178. [PMID: 33272744 DOI: 10.1016/j.meddos.2020.11.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 10/08/2020] [Accepted: 11/07/2020] [Indexed: 11/22/2022]
Abstract
We aimed to compare prototype treatment plans for a new biology-guided radiotherapy (BgRT) machine in its intensity-modulated radiation therapy (IMRT) mode with those using existing IMRT delivery techniques in treatment of nasopharyngeal carcinoma (NPC). We retrospectively selected ten previous NPC patients treated in 33 fractions according to the NRG-HN001 treatment protocol. Three treatment plans were generated for each patient: a helical tomotherapy (HT) plan with a 2.5-cm jaw, a volumetric modulated arc therapy (VMAT) plan using 2 to 4 6-MV arc fields, and a prototype IMRT plan for a new BgRT system which uses a 6-MV photon beam on a ring gantry that rotates at 60 rotations per minute with a couch that moves in small incremental steps. Treatment plans were compared using dosimetric parameters to planning target volumes (PTVs) and organs at risk (OARs) as specified by the NRG-HN001 protocol. Plans for the three modalities had comparable dose coverage, mean dose, and dose heterogeneity to the primary PTV, while the prototype IMRT plans had greater dose heterogeneity to the non-primary PTVs, with the average homogeneity index ranging from 1.28 to 1.50 in the prototype plans. Six of all the 7 OAR mean dose parameters were lower with statistical significance in the prototype plans compared to the HT and VMAT plans with the other mean dose parameter being comparable, and all the 18 OAR maximum dose parameters were comparable or lower with statistical significance in the prototype plans. The average left and right parotid mean doses in the prototype plans were 10.5 Gy and 10.4 Gy lower than those in the HT plans, respectively, and were 5.1 Gy and 5.2 Gy lower than those in the VMAT plans, respectively. Compared to that with the HT and VMAT plans, the treatment time was longer with statistical significance with the prototype IMRT plans. Based on dosimetric comparison of ten NPC cases, the prototype IMRT plans achieved comparable or better critical organ sparing compared to the HT and VMAT plans for definitive NPC radiotherapy. However, there was higher dose heterogeneity to non-primary targets and longer estimated treatment time with the prototype plans.
Collapse
|
9
|
Thiyagarajan R, Sharma DS, Kaushik S, Sawant M, Ganapathy K, Nambi Raj NA, Chilukuri S, Sundar SC, Patro KC, Manikandan A, Noufal MP, Sivaraman R, Easow J, Jalali R. Leaf open time sinogram (LOTS): a novel approach for patient specific quality assurance of total marrow irradiation. Radiat Oncol 2020; 15:236. [PMID: 33054792 PMCID: PMC7557063 DOI: 10.1186/s13014-020-01669-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Accepted: 09/17/2020] [Indexed: 11/10/2022] Open
Abstract
There is no ideal detector-phantom combination to perform patient specific quality assurance (PSQA) for Total Marrow (TMI) and Lymphoid (TMLI) Irradiation plan. In this study, 3D dose reconstruction using mega voltage computed tomography detectors measured Leaf Open Time Sinogram (LOTS) was investigated for PSQA of TMI/TMLI patients in helical tomotherapy. The feasibility of this method was first validated for ten non-TMI/TMLI patients, by comparing reconstructed dose with (a) ion-chamber (IC) and helical detector array (ArcCheck) measurement and (b) planned dose distribution using 3Dγ analysis for 3%@3mm and dose to 98% (D98%) and 2% (D2%) of PTVs. Same comparison was extended for ten treatment plans from five TMI/TMLI patients. In all non-TMI/TMLI patients, reconstructed absolute dose was within ± 1.80% of planned and IC measurement. The planned dose distribution agreed with reconstructed and ArcCheck measured dose with mean (SD) 3Dγ of 98.70% (1.57%) and 2Dγ of 99.48% (0.81%). The deviation in D98% and D2% were within 1.71% and 4.10% respectively. In all 25 measurement locations from TMI/TMLI patients, planned and IC measured absolute dose agreed within ± 1.20%. Although sectorial fluence verification using ArcCHECK measurement for PTVs chest from the five upper body TMI/TMLI plans showed mean ± SD 2Dγ of 97.82% ± 1.27%, the reconstruction method resulted poor mean (SD) 3Dγ of 92.00% (± 5.83%), 64.80% (± 28.28%), 69.20% (± 30.46%), 60.80% (± 19.37%) and 73.2% (± 20.36%) for PTVs brain, chest, torso, limb and upper body respectively. The corresponding deviation in median D98% and D2% of all PTVs were < 3.80% and 9.50%. Re-optimization of all upper body TMI/TMLI plans with new pitch and modulation factor of 0.3 and 3 leads significant improvement with 3Dγ of 100% for all PTVs and median D98% and D2% < 1.6%. LOTS based PSQA for TMI/TMLI is accurate, robust and efficient. A field width, pitch and modulation factor of 5 cm, 0.3 and 3 for upper body TMI/TMLI plan is suggested for better dosimetric outcome and PSQA results.
Collapse
Affiliation(s)
- Rajesh Thiyagarajan
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India.,School of Advanced Sciences, VIT University, Vellore, 632014, India
| | | | - Suryakant Kaushik
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Mayur Sawant
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - K Ganapathy
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - N Arunai Nambi Raj
- Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT), VIT University, Vellore, 632014, India
| | - Srinivas Chilukuri
- Department of Radiation Oncology, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Sham C Sundar
- Department of Radiation Oncology, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Kartikeswar Ch Patro
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Arjunan Manikandan
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - M P Noufal
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Rangasamy Sivaraman
- Department of Medical Physics, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| | - Jose Easow
- Department of Haematology, Blood and Marrow Transplantation, Apollo Speciality Hospital, Teynampet, Chennai, India
| | - Rakesh Jalali
- Department of Radiation Oncology, Apollo Proton Cancer Centre, 100 Feet Road Tharamani, Chennai, 600096, Tamil Nadu, India
| |
Collapse
|
10
|
Santos T, Ventura T, Mateus J, Capela M, Lopes MDC. On the complexity of helical tomotherapy treatment plans. J Appl Clin Med Phys 2020; 21:107-118. [PMID: 32363800 PMCID: PMC7386195 DOI: 10.1002/acm2.12895] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2020] [Revised: 04/09/2020] [Accepted: 04/13/2020] [Indexed: 11/08/2022] Open
Abstract
PURPOSE Multiple metrics are proposed to characterize and compare the complexity of helical tomotherapy (HT) plans created for different treatment sites. METHODS A cohort composed of 208 HT plans from head and neck (105), prostate (51) and brain (52) tumor sites was considered. For each plan, 14 complexity metrics were calculated. Those metrics evaluate the percentage of leaves with small opening times or approaching the projection duration, the percentage of closed leaves, the amount of tongue-and-groove effect, and the overall modulation of the planned sinogram. To enable data visualization, an approach based on principal component analysis was followed to reduce the dataset dimensionality. This allowed the calculation of a global plan complexity score. The correlation between plan complexity and pretreatment verification results using the Spearman's rank correlation coefficients was investigated. RESULTS According to the global score, the most complex plans were the head and neck tumor cases, followed by the prostate and brain lesions irradiated with stereotactic technique. For almost all individual metrics, head and neck plans confirmed to be the plans with the highest complexity. Nevertheless, prostate cases had the highest percentage of leaves with an opening time approaching the projection duration, whereas the stereotactic brain plans had the highest percentage of closed leaves per projection. Significant correlations between some of the metrics and the pretreatment verification results were identified for the stereotactic brain group. CONCLUSIONS The proposed metrics and the global score demonstrated to be useful to characterize and quantify the complexity of HT plans of different treatment sites. The reported differences inter- and intra-group may be valuable to guide the planning process aiming at reducing uncertainties and harmonize planning strategies.
Collapse
Affiliation(s)
- Tania Santos
- Physics Department, University of Coimbra, Coimbra, Portugal.,Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Tiago Ventura
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Josefina Mateus
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | - Miguel Capela
- Medical Physics Department, IPOCFG, E.P.E, Coimbra, Portugal
| | | |
Collapse
|
11
|
Howitz S, Wiezorek T, Wittig A, Vorwerk H, Zink K. Fluence-weighted average subfield size in helical TomoTherapy. Z Med Phys 2019; 29:337-348. [PMID: 31056376 DOI: 10.1016/j.zemedi.2019.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 03/29/2019] [Accepted: 03/30/2019] [Indexed: 11/25/2022]
Abstract
INTRODUCTION Helical TomoTherapy allows a highly conformal dose distribution to complex target geometries with a good protection of organs at risk. However, the small field sizes associated with this method are a possible source of dosimetrical uncertainties. The IAEA has published detector-specific field output correction factors for static fields of the TomoTherapy in the TRS483. This work investigates the average subfield size of helical TomoTherapy plans. MATERIAL AND METHODS A new parameter for helical TomoTherapy was defined - the fluence-weighted average subfield size. The subfield sizes were extracted from the leaf-opening time sinograms in the RT-plan files for 30 clinical prostate and head and neck plans and were put in relation to Delat4 Phantom+ measurement results. Additionally the influence of planning parameters on the subfield size was studied by varying the modulation factor, number of iterations and pitch in the dose optimization and calculation for three different clinical indications H&N, prostate and rectum cancer. Selected plans were dosimetrically verified by Delta4 measurements to examine the reliability in dependence of the average subfield size. Furthermore, the impact of the planning parameters on a) the dose distribution, with regard to the planning target volume and regions at risks, and b) machine characteristics such as delivery time, actual modulation factor and leaf-opening times were evaluated. RESULTS The average equivalent square subfield lengths (s¯eq) of the two investigated indications did not differ significantly - prostate plans: 2.75±0.14cm and H&N plans: 2.70±0.16cm, both with a jaw width of 2.5cm. No correlation between field size and measured dose deviation was detected. The number of iterations and the modulation factor have a considerable influence on the average subfield size. The higher the planned modulation factor and the more iterations are used during optimization, the smaller is the subfield size. In our pilot study plans were calculated with field sizes s¯eq between 4.2cm and 1.7cm, with a jaw width of 2.5cm. Again, the measurement results of Delta4 showed no significant deviation from the doses calculated by the TomoTherapy planning system for the whole range of subfield sizes, and no significant correlation between field sizes and dose deviations was found. As expected, the clinical dose distribution improved with increasing modulation factor and an increasing number of iterations. The compromise between an improved dose distribution and smaller s¯eq was shown. CONCLUSION In this work, a method was presented to determine the average subfield size for helical TomoTherapy plans. The response of the Delta4 did not show any dependence on field size in the range of the field sizes covered by the studied plans. The influence of the subfield sizes on other dosimetry systems remains to be investigated.
Collapse
Affiliation(s)
- Simon Howitz
- University Hospital Jena, Department of Radiation Oncology, Germany; Institute for Medical Physics and Radiation Protection IMPS, University of Applied Science - THM, Giessen, Germany; Philipps-University, Marburg, Germany.
| | - Tilo Wiezorek
- University Hospital Jena, Department of Radiation Oncology, Germany
| | - Andrea Wittig
- University Hospital Jena, Department of Radiation Oncology, Germany
| | | | - Klemens Zink
- Institute for Medical Physics and Radiation Protection IMPS, University of Applied Science - THM, Giessen, Germany; University Medical Center Giessen-Marburg, Department of Radiation Oncology, Germany; Frankfurt Institute for Advanced Studies (FIAS), Frankfurt, Germany
| |
Collapse
|
12
|
Boyd R, Jeong K, Tomé WA. Determining efficient helical IMRT modulation factor from the MLC leaf-open time distribution on precision treatment planning system. J Appl Clin Med Phys 2019; 20:64-74. [PMID: 30957967 PMCID: PMC6523016 DOI: 10.1002/acm2.12581] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2018] [Revised: 02/21/2019] [Accepted: 03/01/2019] [Indexed: 11/21/2022] Open
Abstract
Purpose Since the modulation factor (MF) impacts both plan quality and delivery efficiency in tomotherapy Intensity Modulated Radiation Therapy (IMRT) treatment planning, the purpose of this study was to demonstrate a technique in determining an efficient MF from the Multileaf Collimator (MLC) leaf‐open time (LOT) distribution of a tomotherapy treatment delivery plan. Methods Eight clinical plans of varying complexity were optimized with the highest allowed MF on the Accuracy Precision treatment planning system. Using a central limit theorem argument a range of reduced MFs were then determined from the first two moments of the LOT distribution. A step down approach was used to calculate the reduced‐MF plans and plan comparison tools available on the Precision treatment planning system were used to evaluate dose differences with the reference plan. Results A reduced‐MF plan that balanced delivery time and dosimetric quality was found from the set of five MFs determined from the LOT distribution of the reference plan. The reduced‐MF plan showed good agreement with the reference plan (target and critical organ dose‐volume region of interest dose differences were within 1% and 2% of prescription dose, respectively). Discussion Plan evaluation and acceptance criteria can vary depending on individual clinical expectations and dosimetric quality trade‐offs. With the scheme presented in this paper a planner should be able to efficiently generate a high‐quality plan with efficient delivery time without knowing a good MF beforehand. Conclusion A methodology for deriving a reduced MF from the LOT distribution of a high MF treatment plan using the central limit theorem has been presented. A scheme for finding a reduced MF from a set of MFs that results in a plan balanced in both dosimetric quality and treatment delivery efficiency has also been presented.
Collapse
Affiliation(s)
- Robert Boyd
- Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Kyoungkeun Jeong
- Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Wolfgang A Tomé
- Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
| |
Collapse
|
13
|
Haraldsson A, Engellau J, Lenhoff S, Engelholm S, Bäck S, Engström PE. Implementing safe and robust Total Marrow Irradiation using Helical Tomotherapy - A practical guide. Phys Med 2019; 60:162-167. [PMID: 31000078 DOI: 10.1016/j.ejmp.2019.03.032] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 03/22/2019] [Accepted: 03/30/2019] [Indexed: 11/16/2022] Open
Abstract
Total Marrow Irradiation (TMI) with Helical Tomotherapy is a radiotherapy treatment technique that targets bone marrow and sanctuary sites prior to stem cell or bone marrow transplantation (SCT/BMT). TMI is a complex procedure that involves several critical steps that all need to be carefully addressed for a successful implementation, such as dose homogeneity in field junctions, choice of target margins, integrity of treatment and back-up planning. In this work we present our solution for a robust and reproducible workflow throughout the treatment chain and data for twenty-three patients treated to date. MATERIAL & METHODS Patients were immobilized in a whole body vacuum cushion and thermoplastic mask. CT-scanning and treatment were performed in two parts with field matching at the upper thigh. Target consisted of marrow containing bone and sanctuary sites. Lungs, kidneys, bowel, heart and liver were defined as organs at risk (OAR). A fast surface scanning system was used to position parts of the body not covered by the imaging system (MVCT) as well as to reduce treatment time. RESULTS All patients completed their treatment and could proceed with SCT/BMT. Doses to OARs were significantly reduced and target dose homogeneity was improved compared to TBI. Robustness tests performed on field matching and patient positioning support that the field junction technique is adequate. Replacing MVCT with optical surface scanning reduced the treatment time by 25 min per fraction. CONCLUSION The methodology presented here has shown to provide a safe, robust and reproducible treatment for Total Marrow Irradiation using Tomotherapy.
Collapse
Affiliation(s)
- André Haraldsson
- Medical Radiation Physics, Lund University, Lund, Sweden; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
| | - Jacob Engellau
- Medical Radiation Physics, Lund University, Lund, Sweden; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - Stig Lenhoff
- Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - Silke Engelholm
- Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - Sven Bäck
- Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - Per E Engström
- Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| |
Collapse
|
14
|
Calculation and measurement of doses in the surface layers of a phantom when using Tomotherapy. Rep Pract Oncol Radiother 2019; 24:251-262. [DOI: 10.1016/j.rpor.2018.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2018] [Revised: 11/27/2018] [Accepted: 11/30/2018] [Indexed: 11/17/2022] Open
|
15
|
Kasai Y, Fukuyama Y, Terashima H, Nakamura K, Sasaki T. Dose evaluation indices for total body irradiation using TomoDirect with different numbers of ports: A comparison with the TomoHelical method. J Appl Clin Med Phys 2019; 20:129-135. [PMID: 30721567 PMCID: PMC6370990 DOI: 10.1002/acm2.12540] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Revised: 12/17/2018] [Accepted: 01/08/2019] [Indexed: 11/09/2022] Open
Abstract
TomoDirect has been reported to have some advantages over TomoHelical in delivering total body irradiation (TBI). This study aimed to investigate the relationships between the number of ports and the dose evaluation indices in low‐dose TBI in TomoDirect mode using 2–12 ports and to compare these data with those for the TomoHelical mode in a simulation study. Thirteen patients underwent low‐dose TBI in TomoHelical mode from June 2015 to June 2016. We used the same computed tomography data sets for these patients to create new treatment plans for upper‐body parts using TomoDirect mode with 2–12 beam angles as well as TomoHelical mode. The prescription was 4 Gy in two equal fractions. For the TomoDirect data, we generated plans with 2–12 ports with approximately equally spaced angles; the modulation factor, field width, and pitch were 2.0, 5.0 cm, and 0.500, respectively. For the TomoHelical plans, the modulation factor, field width, and pitch were 2.0, 5.0 cm, and 0.397, respectively. D2, D98, D50, and the homogeneity index (HI) were evaluated to compare TomoDirect plans having 2–12 ports with the TomoHelical plan. Using TomoDirect plans, D2 with four ports or fewer, D98 with 10 ports or fewer, D50 with four ports or fewer and HI with five ports or fewer showed statistically significantly worse results than the TomoHelical plan. With the TomoDirect plans, D2 with seven ports or more, D50 with eight ports or more, and HI with eight ports or more showed statistically significant improvement compared with the TomoHelical plan. All of the dose evaluation indices of the TomoDirect plans showed a tendency to improve as the number of ports increased. TomoDirect plans showed statistically significant improvement of D2, D50, and HI compared with the TomoHelical plan. Therefore, we conclude that TomoDirect can provide better dose distribution in low‐dose TBI with TomoTherapy.
Collapse
Affiliation(s)
- Yuki Kasai
- Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka City, Fukuoka, 812-8582, Japan
| | - Yukihide Fukuyama
- Department of Radiology, Harasanshin Hospital, 1-8 Taihakumachi, Hakata-ku, Fukuoka City, Fukuoka, 812-0033, Japan
| | - Hiromi Terashima
- Department of Radiology, Harasanshin Hospital, 1-8 Taihakumachi, Hakata-ku, Fukuoka City, Fukuoka, 812-0033, Japan
| | - Katsumasa Nakamura
- Department of Radiation Oncology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka, 431-3192, Japan
| | - Tomonari Sasaki
- Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka City, Fukuoka, 812-8582, Japan
| |
Collapse
|
16
|
Madhusudhana Sresty NVN, Raju AK, Reddy BN, Sahithya VC, Mohmd Y, Kumar GD, Kumar TA, Rushdi T, Aparna S, Prasad GD, Bajwa HK. Evaluation and Validation of IBA I'MatriXX Array for Patient-Specific Quality Assurance of TomoTherapy ®. J Med Phys 2019; 44:222-227. [PMID: 31576071 PMCID: PMC6764175 DOI: 10.4103/jmp.jmp_11_19] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
TomoTherapy® is a modern radiation treatment technique in which intensity-modulated radiation therapy (IMRT) is delivered in helical fashion. A two-dimensional (2D) array which has been existing for IMRT patient-specific quality assurance (PSQA) verifications for many years is I'MatriXX. Our objectives were to validate this I'MatriXX and to evaluate it for different patient sites and fractionation schedules of TomoTherapy treatment. Twenty-five plans were created with virtual target for different possible pitch values and field widths for validation. Gamma index criteria of 3%/2% dose differences and 3/2 mm distance to agreement were used. QA plans of 26 different treatment sites and different fractionation schedules were used. Results indicated that the matrix response is independent of field width, pitch, and modulation factor of TomoTherapy with 3%, 3 mm criteria. High passing rate ranging from 99.7% to 90.7% was observed for selected patient plans. We found that I'MatriXX 2D array can be utilized for easy and quick TomoTherapy PSQA.
Collapse
Affiliation(s)
- N V N Madhusudhana Sresty
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - A Krishnam Raju
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - B Nagarjuna Reddy
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - V C Sahithya
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - Yakub Mohmd
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - G Deleep Kumar
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - T Anil Kumar
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - Tasneem Rushdi
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - S Aparna
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| | - G Durga Prasad
- Department of Radiotherapy, Government Medical College and General Hospital, Anantapuramu, Andhra Pradesh, India
| | - Harjot Kaur Bajwa
- Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India
| |
Collapse
|
17
|
Binny D, Lancaster CM, Byrne M, Kairn T, V Trapp J, Crowe SB. Tomotherapy treatment site specific planning using statistical process control. Phys Med 2018; 53:32-39. [PMID: 30241752 DOI: 10.1016/j.ejmp.2018.08.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2018] [Revised: 06/26/2018] [Accepted: 08/05/2018] [Indexed: 10/28/2022] Open
Abstract
BACKGROUND This study investigated planned MLC distribution and treatment region specific plan parameters to recommend optimal delivery parameters based on statistical process techniques. METHODS A cohort of 28 head and neck, 19 pelvic and 23 brain pre-treatment plans were delivered on a helical tomotherapy system using 2.5 cm field width. Parameters such as gantry period, leaf open time (LOT), actual modulation factor, LOT sonogram, treatment duration and couch travel were investigated to derive optimal range for plans that passed acceptable delivery quality assurance. The results were compared against vendor recommendations and previous publications. RESULTS No correlation was observed between vendor recommended gantry period and percentage of minimum leaf open times. The range of gantry period (min-max) observed was 16-21 s for head and neck, 15-22 s for pelvis and 13-18 s for brain plans respectively. It was also noted that the highest percentage (average (X-) ± SD) of leaf open times for a minimum time of 100 ms was seen for brain plans (53.9 ± 9.2%) compared to its corresponding head and neck (34.5 ± 4.2%) and pelvic (32.0 ± 9.4%) plans respectively. CONCLUSIONS We have proposed that treatment site specific delivery parameters be used during planning that are based on the treatment centre and have detailed recommendations and limitations for the studied cohort. This may enable to improve efficiency of treatment deliveries by reducing inaccuracies in MLC distribution.
Collapse
Affiliation(s)
- Diana Binny
- Radiation Oncology Centres, Redlands, Australia; Queensland University of Technology, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.
| | - Craig M Lancaster
- Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - Mikel Byrne
- Radiation Oncology Centres, Wahroonga, Australia
| | - Tanya Kairn
- Queensland University of Technology, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| | - Jamie V Trapp
- Queensland University of Technology, Brisbane, Australia
| | - Scott B Crowe
- Queensland University of Technology, Brisbane, Australia; Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia
| |
Collapse
|
18
|
Shimizu H, Sasaki K, Kubota T, Fukuma H, Aoyama T, Iwata T, Tachibana H, Kodaira T. Interfacility variation in treatment planning parameters in tomotherapy: field width, pitch, and modulation factor. JOURNAL OF RADIATION RESEARCH 2018; 59:664-668. [PMID: 29868727 PMCID: PMC6151637 DOI: 10.1093/jrr/rry042] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/04/2018] [Revised: 03/02/2018] [Indexed: 06/08/2023]
Abstract
Several studies have reported changes in dose distribution and delivery time based on the value of specific planning parameters [field width (FW), pitch, and modulation factor (MF)] in tomotherapy. However, the variation in the parameters between different facilities is unknown. The purpose of this study was to determine standard values of the above parameters for cases of head and neck cancer (HNC) and prostate cancer (PC) in Japan. In this survey, a web-based questionnaire was sent to 48 facilities performing radiation therapy with tomotherapy in March 2016. The deadline for data submission was April 2016. In the questionnaire, the values of the planning parameters usually used were requested and 23 responses were received, representing a response rate of 48% (23/48). The FW selected was 2.5 cm in most facilities, and facilities with a tomoEDGE license used dynamic FW rather than fixed FW. Facilities changed the pitch based on FW, dose per fraction, or target offset more frequently in HNC than in PC. In contrast, >50% of the facilities used the magic number proposed by Kissick et al. Median preset MFs (range, min to max) in HNC and PC were 2.4 (1.8-2.8) and 2.0 (1.8-3.0), respectively, and MF values showed large variations between the facilities. Our results are likely to be useful to several facilities designing treatment plans in tomotherapy.
Collapse
Affiliation(s)
- Hidetoshi Shimizu
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
- Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki, Maebashi, Gunma, Japan
| | - Koji Sasaki
- Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, 323-1 Kamioki, Maebashi, Gunma, Japan
| | - Takashi Kubota
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
| | - Hiroshi Fukuma
- Department of Radiology, Nagoya City University Hospital, 1-Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan
| | - Takahiro Aoyama
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
| | - Tohru Iwata
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
| | - Hiroyuki Tachibana
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
| | - Takeshi Kodaira
- Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-Ku, Nagoya, Aichi, Japan
| |
Collapse
|
19
|
Hui C, Chen Q, Khandelwal S, Neal B, Watkins W. Detection of dose delivery variations on TomoTherapy using on-board detector based verification. Phys Med Biol 2018; 63:14NT02. [DOI: 10.1088/1361-6560/aacebb] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
20
|
Investigating output and energy variations and their relationship to delivery QA results using Statistical Process Control for helical tomotherapy. Phys Med 2017; 38:105-110. [DOI: 10.1016/j.ejmp.2017.05.052] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2016] [Revised: 05/04/2017] [Accepted: 05/04/2017] [Indexed: 11/19/2022] Open
|
21
|
Shimizu H, Sasaki K, Tachibana H, Tomita N, Makita C, Nakashima K, Yokoi K, Kubota T, Yoshimoto M, Iwata T, Kodaira T. Analysis of modulation factor to shorten the delivery time in helical tomotherapy. J Appl Clin Med Phys 2017; 18:83-87. [PMID: 28444831 PMCID: PMC5689868 DOI: 10.1002/acm2.12075] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 02/14/2017] [Accepted: 02/17/2017] [Indexed: 11/12/2022] Open
Abstract
A low modulation factor (MF) maintaining a good dose distribution contributes to the shortening of the delivery time and efficiency of the treatment plan in helical tomotherapy. The purpose of this study was to reduce the delivery time using initial values and the upper limit values of MF. First, patients with head and neck cancer (293 cases) or prostate cancer (181 cases) treated between June 2011 and July 2015 were included in the analysis of MF values. The initial MF value (MFinitial ) was defined as the average MFactual value, and the upper limit of the MF value (MFUL ) was defined according the following equation: MFUL = 2 × standard deviation of MFactual value + the average MFactual Next, a treatment plan was designed for patients with head and neck cancer (62 cases) and prostate cancer (13 cases) treated between December 2015 and June 2016. The average MFactual value for the nasopharynx, oropharynx, hypopharynx, and prostate cases decreased from 2.1 to 1.9 (p = 0.0006), 1.9 to 1.6 (p < 0.0001), 2.0 to 1.7 (p < 0.0001), and 1.8 to 1.6 (p = 0.0004) by adapting the MFinitial and the MFUL values, respectively. The average delivery time for the nasopharynx, oropharynx, hypopharynx, and prostate cases also decreased from 19.9 s cm-1 to 16.7 s cm-1 (p < 0.0001), 15.0 s cm-1 to 13.9 s cm-1 (p = 0.025), 15.1 s cm-1 to 13.8 s cm-1 (p = 0.015), and 23.6 s cm-1 to 16.9 s cm-1 (p = 0.008) respectively. The delivery time was shortened by the adaptation of MFinitial and MFUL values with a reduction in the average MFactual for head and neck cancer and prostate cancer cases.
Collapse
Affiliation(s)
- Hidetoshi Shimizu
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Koji Sasaki
- Department of radiation therapy education and research, Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences, Maebashi, Gunma, Japan
| | - Hiroyuki Tachibana
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Natsuo Tomita
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Chiyoko Makita
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Kuniyasu Nakashima
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Kazushi Yokoi
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Takashi Kubota
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Manabu Yoshimoto
- Department of Radiology, Aichi Cancer Center Aichi Hospital, Okazaki, Aichi, Japan
| | - Tohru Iwata
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| | - Takeshi Kodaira
- Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
| |
Collapse
|
22
|
Deshpande S, Geurts M, Vial P, Metcalfe P, Lee M, Holloway L. Clinical significance of treatment delivery errors for helical TomoTherapy nasopharyngeal plans – A dosimetric simulation study. Phys Med 2017; 33:159-169. [PMID: 28110824 DOI: 10.1016/j.ejmp.2017.01.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2016] [Revised: 12/06/2016] [Accepted: 01/07/2017] [Indexed: 11/17/2022] Open
Affiliation(s)
- Shrikant Deshpande
- Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
| | - Mark Geurts
- Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, USA.
| | - Philip Vial
- Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia; Institute of Medical Physics, School of Physics, University of Sydney, Sydney, NSW, Australia.
| | - Peter Metcalfe
- Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia.
| | - Mark Lee
- Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia.
| | - Lois Holloway
- Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia; Institute of Medical Physics, School of Physics, University of Sydney, Sydney, NSW, Australia; South West Clinical School, University of New South Wales, Sydney, NSW, Australia.
| |
Collapse
|
23
|
Peñagarícano JA, Shi C, Ratanatharathorn V. Evaluation of Integral Dose in Cranio-spinal Axis (CSA) Irradiation with Conventional and Helical Delivery. Technol Cancer Res Treat 2016; 4:683-9. [PMID: 16292889 DOI: 10.1177/153303460500400613] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
In cranio-spinal axis (CSA) irradiation, patients are usually treated in the prone position with junctions between cranial and spinal fields. Collimator angle and pedestal rotations are introduced to obtain coplanar alignment of the matched junction. Furthermore, daily moving junctions are commonly used to feather out the junctional dose as additional safe-guards to avoid radiation myelopathy. Helical tomotherapy integrates linear accelerator and CT technology capable of delivering CSA treatment without geometric matches or feathering of junctions. The patient is treated with helical beams in the supine position. Since CSA is used mainly in the pediatric population, the potential increase in integral dose to structures or the whole body from linac- or tomotherapy-based IMRT raises concerns of increased rates of secondary malignancies. In this study, we will present an integral dose comparison between conventional CSA (3D) and helical delivery to the CSA (TOMO) utilizing the Tomotherapy Hi-ART system for three pediatric patients. Integral dose was calculated for organ at risk (OAR), two targets (PTV-BRAIN and PTV-SPINE), entire planning CT data set and to the healthy tissue (entire CT-DATA SET minus the PTV). Overall integral dose was 8% higher in the TOMO plans for Patients #1 and #3, but 2% lower in Patient #2. DVH analysis shows that TOMO plans give lower doses to larger volumes and higher doses to smaller volumes of tissue in all three cases. The advantages of the TOMO plans are minimization of matched junctions and better sparing of most OARs. With increased computational and memory power in the tomotherapy planning station, the excess integral dose to the healthy tissue can be re-distributed within the patient and in turn the total integral dose can be same or lower than in conventional delivery. The impact of a small increase in overall integral dose and the associated risks of secondary malignancies are unknown. Long-term follow-up is needed to answer this question.
Collapse
Affiliation(s)
- José A Peñagarícano
- Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, 72205, USA.
| | | | | |
Collapse
|
24
|
Yawichai K, Chitapanarux I, Wanwilairat S. Helical tomotherapy optimized planning parameters for nasopharyngeal cancer. ACTA ACUST UNITED AC 2016. [DOI: 10.1088/1742-6596/694/1/012002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
25
|
Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless? Radiat Oncol 2015; 10:261. [PMID: 26701749 PMCID: PMC4690403 DOI: 10.1186/s13014-015-0556-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Accepted: 11/23/2015] [Indexed: 11/17/2022] Open
Abstract
Background The last few years, in radiotherapy there has been a growing focus on speed of treatment delivery (largely driven by economical and commercial interests). This study investigates the influence of treatment time on plan quality for helical tomotherapy (HT), using delivery times with Volumetric Modulated Arc Therapy (VMAT; Rapid Arc [RA]) as reference. Methods In a previous study, double arc RA (Eclipse) and standard HT plans (TomoHD™) were created for five oropharyngeal cancer patients and reported according to ICRU 83 guidelines. By modifying the beam width from 2.5 to 5.0 cm, elevating the pitch and lowering the modulation factor, “TomoFast” (TF) plans were generated with treatment times equal to RA plans. To quantify the impact of TF’s craniocaudal gradient, similar plans were generated on TomoEdgeTM (TomoEdgeFast;TEF). The homogeneity index (HI), conformity index (CI), mean dose, Dnear-max (D2) and Dnear-min (D98) of the PTVs were analyzed as well as the mean dose, specific critical doses and volumes of 26 organs at risk (OARs). Data were analyzed using repeated measures ANOVA. Results With a mean treatment time of 3.05 min (RA), 2.89 min (TF) and 2.95 min (TEF), PTVtherapeutic coverage was more homogeneous with TF (HI.07;SE.01) and TEF (HI.08;SE.01) compared to RA (HI.10;SE.01), while PTVprophylactic was most homogeneous with RA. Mean doses to parotid glands were comparable for RA, TF, TEF: 25.62, 25.34, 23.09 Gy for contralateral and 32.02, 31.96, 30.01 Gy for ipsilateral glands, respectively. OARs’ mean doses varied between different approaches not favoring a particular technique. TF’s higher dose to OARs at the cranial-caudal edges of the PTVs and its higher integral dose, both due to the extended cranial-caudal gradient, seems to be solved by the new TomoEdge™ software. However, all these faster techniques lose part of standard TomoHD’s OAR sparing capacity Conclusion It is possible to treat oropharyngeal cancer patients using HT (TF/TEF) within time-frames observed for RA maintaining comparable target coverage and sparing of OARs. This study indicates that treatment time is not technology specific, rather an operator’s decision on balancing efficiency and quality.
Collapse
|
26
|
Marrazzo L, Zani M, Pallotta S, Arilli C, Casati M, Compagnucci A, Talamonti C, Bucciolini M. GafChromic(®) EBT3 films for patient specific IMRT QA using a multichannel approach. Phys Med 2015; 31:1035-1042. [PMID: 26429383 DOI: 10.1016/j.ejmp.2015.08.010] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2015] [Revised: 07/28/2015] [Accepted: 08/22/2015] [Indexed: 10/23/2022] Open
Abstract
PURPOSE To evaluate EBT3 for pre-treatment patient specific quality assurance (QA). The method we propose combines the experience gained in our center with the guidelines of the protocol proposed by Lewis et al. in 2012. To compare the multichannel approach with the single channel dosimetry. METHODS Gafchromic® EBT3 films were irradiated both at linac and TomoTherapy and calibration curves were obtained. A series of irradiations with simple fields (uniform dose distributions on regular shaped targets) was performed. In a second stage, films were exposed to full clinical plans at linac (step and shoot IMRT and VMAT). At TomoTherapy dose maps were obtained for a clinical plan in three different coronal planes. Films were digitized using an Epson 10000XL scanner and FilmQA™ Pro software was employed for the analysis. RESULTS The measured calibration curves suggest that, at least for the two beams taken into account (6 MV linac and TomoTherapy), a single calibration can be successfully adopted for each film lot. The application of the multichannel optimization method strongly improves the results in terms of gamma passing rates of the comparison between measured and calculated maps. CONCLUSIONS Up to now EBT films, although attractive, were not preferred for routine patient specific QA due to their complex and time consuming processing and to the challenging work of characterization. The application of the mentioned protocol, together with some additional precautions, and the adoption of the multichannel optimization dosimetry, make this detector a handy and reliable tool for patient specific QA.
Collapse
Affiliation(s)
- Livia Marrazzo
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
| | - Margherita Zani
- Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, Florence, Italy
| | - Stefania Pallotta
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, Florence, Italy
| | - Chiara Arilli
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
| | - Marta Casati
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
| | | | - Cinzia Talamonti
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, Florence, Italy
| | - Marta Bucciolini
- Medical Physics Unit, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Dipartimento di Scienze Biomediche, Sperimentali e Cliniche, Università degli Studi di Firenze, Florence, Italy
| |
Collapse
|
27
|
De Kerf G, Van Gestel D, Mommaerts L, Van den Weyngaert D, Verellen D. Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts. Radiat Oncol 2015; 10:191. [PMID: 26377574 PMCID: PMC4573943 DOI: 10.1186/s13014-015-0497-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 09/03/2015] [Indexed: 11/25/2022] Open
Abstract
Background Modulation factor (MF) and pitch have an impact on Helical TomoTherapy (HT) plan quality and HT users mostly use vendor-recommended settings. This study analyses the effect of these two parameters on both plan quality and treatment time for plans made with TomoEdge planning software by using the concept of Pareto optimal fronts. Methods More than 450 plans with different combinations of pitch [0.10–0.50] and MF [1.2–3.0] were produced. These HT plans, with a field width (FW) of 5 cm, were created for five head and neck patients and homogeneity index, conformity index, dose-near-maximum (D2), and dose-near-minimum (D98) were analysed for the planning target volumes, as well as the mean dose and D2 for most critical organs at risk. For every dose metric the median value will be plotted against treatment time. A Pareto-like method is used in the analysis which will show how pitch and MF influence both treatment time and plan quality. Results For small pitches (≤0.20), MF does not influence treatment time. The contrary is true for larger pitches (≥0.25) as lowering MF will both decrease treatment time and plan quality until maximum gantry speed is reached. At this moment, treatment time is saturated and only plan quality will further decrease. Conclusion The Pareto front analysis showed optimal combinations of pitch [0.23–0.45] and MF > 2.0 for a FW of 5 cm. Outside this range, plans will become less optimal. As the vendor-recommended settings fall within this range, the use of these settings is validated.
Collapse
Affiliation(s)
- Geert De Kerf
- Department of Radiotherapy, University Radiotherapy Antwerp (URA), Antwerp, Belgium. .,Present address: Department of Radiotherapy, Iridium Cancer Network, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Wilrijk, Antwerp, Belgium.
| | - Dirk Van Gestel
- Department of Radiotherapy, University Radiotherapy Antwerp (URA), Antwerp, Belgium.,Present address: Department of Radiotherapy, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
| | - Lobke Mommaerts
- Department of Radiotherapy, University Radiotherapy Antwerp (URA), Antwerp, Belgium
| | | | - Dirk Verellen
- Radiotherapy UZ Brussel, Faculty of Medicine and Pharmacy Vrije Universiteit Brussel, Brussels, Belgium
| |
Collapse
|
28
|
Binny D, Lancaster CM, Harris S, Sylvander SR. Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans. J Appl Clin Med Phys 2015; 16:87–105. [PMID: 26699293 PMCID: PMC5690175 DOI: 10.1120/jacmp.v16i5.5282] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2014] [Revised: 02/19/2015] [Accepted: 02/19/2015] [Indexed: 12/25/2022] Open
Abstract
This study was aimed at investigating delivery quality assurance (DQA) discrepancies observed for helical tomotherapy plans. A selection of tomotherapy plans that initially failed the DQA process was chosen for this investigation. These plans failed the fluence analysis as assessed using gamma criteria (3%, 3 mm) with radiographic film. Each of these plans was modified (keeping the planning constraints the same), beamlets rebatched and reoptimized. By increasing and decreasing the modulation factor, the fluence in a circumferential plane as measured with a diode array was assessed. A subset of these plans was investigated using varied pitch values. Metrics for each plan that were examined were point doses, fluences, leaf opening times, planned leaf sinograms, and uniformity indices. In order to ensure that the treatment constraints remained the same, the dose-volume histograms (DVHs) of all the modulated plans were compared to the original plan. It was observed that a large increase in the modulation factor did not significantly improve DVH uniformity, but reduced the gamma analysis pass rate. This also increased the treatment delivery time by slowing down the gantry rotation speed which then increases the maximum to mean non-zero leaf open time ratio. Increasing and decreasing the pitch value did not substantially change treatment time, but the delivery accuracy was adversely affected. This may be due to many other factors, such as the complexity of the treatment plan and site. Patient sites included in this study were head and neck, right breast, prostate, abdomen, adrenal, and brain. The impact of leaf timing inaccuracies on plans was greater with higher modulation factors. Point-dose measurements were seen to be less susceptible to changes in pitch and modulation factors. The initial modulation factor used by the optimizer, such that the TPS generated 'actual' modulation factor within the range of 1.4 to 2.5, resulted in an improved deliverable plan.
Collapse
|
29
|
Meyer P, Bouhours H, Dehaynin N, Jarnet D, Gantier M, Karamanoukian D, Niederst C. The optimal tomotherapy treatment planning parameters for extremity soft tissue sarcomas. Phys Med 2015; 31:542-52. [PMID: 26032005 DOI: 10.1016/j.ejmp.2015.05.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 04/30/2015] [Accepted: 05/07/2015] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND AND PURPOSE To determine the optimum combination of treatment parameters between pitch, field width (FW) and modulation factor (MF) for extremity sarcomas in tomotherapy. MATERIALS AND METHODS Six patients previously treated for extremity sarcomas (3 arms and 3 legs) with tomotherapy were included in this study. 288 treatment plans were recalculated, corresponding to all combinations between 2 FW (2.5 and 5 cm), 4 MF (1.5, 2, 2.5 and 3) and 6 pitches (0.215, 0.287, 0.43 and 3 off-axis pitches). The treatment parameters (MF, FW or pitch) are modified between each plan, and the calculation is relaunched for 400 iterations, without modifying the optimisation constraints of the plan under which the patient has been treated. RESULTS We suggest eliminating the 0.43 pitch and never combining a 0.215 pitch with an MF ≤ 2. We also do not recommend using an MF = 1.5 unless treatment time is an absolute priority over plan quality. We did not see any advantage in using Chen off-axis pitches, except for targets far from the axis (>15 cm) treated with a high pitch. A combination of MF = 2/FW = 5 cm/pitch = 0.287 gives plans of acceptable quality, combined with reduced treatment times. These conclusions are true only for extremity sarcomas treated in 2 Gy/fraction. CONCLUSIONS We have shown that the choice of pitch/MF/FW combination is crucial for the treatment of extremity sarcomas in tomotherapy: some produce good dosimetric quality with a reduced irradiation time, while others may increase the time without improving the quality.
Collapse
Affiliation(s)
- Philippe Meyer
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France.
| | - Hugo Bouhours
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| | - Nicolas Dehaynin
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| | - Delphine Jarnet
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| | - Matthieu Gantier
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| | - Diran Karamanoukian
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| | - Claudine Niederst
- Division of Medical Physics, Department of Radiotherapy, Paul Strauss Center, Strasbourg, France
| |
Collapse
|
30
|
Cao YJ, Lee S, Chang KH, Shim JB, Kim KH, Park YJ, Kim CY. Patient performance-based plan parameter optimization for prostate cancer in tomotherapy. Med Dosim 2015; 40:285-9. [PMID: 25869936 DOI: 10.1016/j.meddos.2015.03.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Accepted: 03/17/2015] [Indexed: 11/18/2022]
Abstract
The purpose of this study is to evaluate the influence of treatment-planning parameters on the quality of treatment plans in tomotherapy and to find the optimized planning parameter combinations when treating patients with prostate cancer under different performances. A total of 3 patients with prostate cancer with Eastern Cooperative Oncology Group (ECOG) performance status of 2 or 3 were included in this study. For each patient, 27 treatment plans were created using a combination of planning parameters (field width of 1, 2.5, and 5cm; pitch of 0.172, 0.287, and 0.43; and modulation factor of 1.8, 3, and 3.5). Then, plans were analyzed using several dosimetrical indices: the prescription isodose to target volume (PITV) ratio, homogeneity index (HI), conformity index (CI), target coverage index (TCI), modified dose HI (MHI), conformity number (CN), and quality factor (QF). Furthermore, dose-volume histogram of critical structures and critical organ scoring index (COSI) were used to analyze organs at risk (OAR) sparing. Interestingly, treatment plans with a field width of 1cm showed more favorable results than others in the planning target volume (PTV) and OAR indices. However, the treatment time of the 1-cm field width was 3 times longer than that of plans with a field width of 5cm. There was no substantial decrease in treatment time when the pitch was increased from 0.172 to 0.43, but the PTV indices were slightly compromised. As expected, field width had the most significant influence on all of the indices including PTV, OAR, and treatment time. For the patients with good performance who can tolerate a longer treatment time, we suggest a field width of 1cm, pitch of 0.172, and modulation factor of 1.8; for the patients with poor performance status, field width of 5cm, pitch of 0.287, and a modulation factor of 3.5 should be considered.
Collapse
Affiliation(s)
- Yuan Jie Cao
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| | - Suk Lee
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea.
| | - Kyung Hwan Chang
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| | - Jang Bo Shim
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| | - Kwang Hyeon Kim
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| | - Young Je Park
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| | - Chul Yong Kim
- Department of Radiation Oncology, College of Medicine, Korea University, Seoul, Korea
| |
Collapse
|
31
|
Fan-shaped complete block on helical tomotherapy for esophageal cancer: a phantom study. BIOMED RESEARCH INTERNATIONAL 2015; 2015:959504. [PMID: 25767810 PMCID: PMC4342177 DOI: 10.1155/2015/959504] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2014] [Revised: 01/13/2015] [Accepted: 01/14/2015] [Indexed: 11/18/2022]
Abstract
Radiation pneumonitis (RP) is a common complication for radiotherapy of esophageal cancer and is associated with the low dose irradiated lung volume. This study aims to reduce the mean lung dose (MLD) and the relative lung volume at 20 Gy (V20) and at low dose region using various designs of the fan-shaped complete block (FSCB) in helical tomotherapy. Hypothetical esophageal tumor was delineated on an anthropomorphic phantom. The FSCB was defined as the fan-shaped radiation restricted area located in both lungs. Seven treatment plans were performed with nonblock design and FSCB with different fan angles, that is, from 90° to 140°, with increment of 10°. The homogeneous index, conformation number, MLD, and the relative lung volume receiving more than 5, 10, 15, and 20 Gy (V5, V10, V15, and V20) were determined for each treatment scheme. There was a substantial reduction in the MLD, V5, V10, V15, and V20 when using different types of FSCB as compared to the nonblock design. The reduction of V20, V15, V10, and V5 was 6.3%–8.6%, 16%–23%, 42%–57%, and 42%–66% for FSCB 90°–140°, respectively. The use of FSCB in helical tomotherapy is a promising method to reduce the MLD, V20, and relative lung volume in low dose region, especially in V5 and V10 for esophageal cancer.
Collapse
|
32
|
Stambaugh C, Nelms B, Wolf T, Mueller R, Geurts M, Opp D, Moros E, Zhang G, Feygelman V. Measurement-guided volumetric dose reconstruction for helical tomotherapy. J Appl Clin Med Phys 2015; 16:5298. [PMID: 26103199 PMCID: PMC5690083 DOI: 10.1120/jacmp.v16i2.5298] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2014] [Revised: 10/20/2014] [Accepted: 10/21/2014] [Indexed: 11/23/2022] Open
Abstract
It was previously demonstrated that dose delivered by a conventional linear accelerator using IMRT or VMAT can be reconstructed - on patient or phantom datasets - using helical diode array measurements and a technique called planned dose perturbation (PDP). This allows meaningful and intuitive analysis of the agreement between the planned and delivered dose, including direct comparison of the dose-volume histograms. While conceptually similar to modulated arc techniques, helical tomotherapy introduces significant challenges to the PDP formalism, arising primarily from TomoTherapy delivery dynamics. The temporal characteristics of the delivery are of the same order or shorter than the dosimeter's update interval (50 ms). Additionally, the prevalence of often small and complex segments, particularly with the 1 cm Y jaw setting, lead to challenges related to detector spacing. Here, we present and test a novel method of tomotherapy-PDP (TPDP) designed to meet these challenges. One of the novel techniques introduced for TPDP is organization of the subbeams into larger subunits called sectors, which assures more robust synchronization of the measurement and delivery dynamics. Another important change is the optional application of a correction based on ion chamber (IC) measurements in the phantom. The TPDP method was validated by direct comparisons to the IC and an independent, biplanar diode array dosimeter previously evaluated for tomotherapy delivery quality assurance. Nineteen plans with varying complexity were analyzed for the 2.5 cm tomotherapy jaw setting and 18 for the 1 cm opening. The dose differences between the TPDP and IC were 1.0% ± 1.1% and 1.1% ± 1.1%, for 2.5 and 1.0 cm jaw plans, respectively. Gamma analysis agreement rates between TPDP and the independent array were: 99.1%± 1.8% (using 3% global normalization/3 mm criteria) and 93.4% ± 7.1% (using 2% global/2 mm) for the 2.5 cm jaw plans; for 1 cm plans, they were 95.2% ± 6.7% (3% G/3) and 83.8% ± 12% (2% G/2). We conclude that TPDP is capable of volumetric dose reconstruction with acceptable accuracy. However, the challenges of fast tomotherapy delivery dynamics make TPDP less precise than the IMRT/VMAT PDP version, particularly for the 1 cm jaw setting.
Collapse
|
33
|
Sugie C, Manabe Y, Hayashi A, Murai T, Takaoka T, Hattori Y, Iwata H, Takenaka R, Shibamoto Y. Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer. Technol Cancer Res Treat 2014; 14:459-65. [PMID: 25398681 PMCID: PMC4535315 DOI: 10.1177/1533034614558746] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2014] [Accepted: 10/06/2014] [Indexed: 11/30/2022] Open
Abstract
The recently developed dynamic jaw technology of tomotherapy can reduce craniocaudal dose spread without much prolonging the treatment time. This study aimed to investigate the efficacy of the dynamic jaw mode for tomotherapy of breast cancer. Static tomotherapy plans of the whole breast and supraclavicular regional lymph nodes, and plans for the whole breast only were generated in 25 patients with left-sided breast cancer. Plans with a field width of 2.5 or 5 cm with the dynamic or fixed jaw modes were made for each patient. The prescribed dose was 50 Gy in 25 fractions. In whole breast and supraclavicular nodal radiotherapy, dose distributions and homogeneity of the planning target volume (PTV) with the dynamic jaw mode were slightly inferior to those with the fixed jaw mode with a 5-cm field width (P < .05). However, lung low-dose volumes and mean doses of the larynx, thyroid, skin, and all the healthy tissues combined were smaller with the dynamic jaw mode than with the fixed jaw mode with a 5-cm field width (P < .001). In whole breast radiotherapy, mean doses of the skin and healthy tissues were lower with the dynamic jaw mode than with the fixed jaw mode with a 5-cm field width (P < .001) without significant differences in PTV dose distributions, homogeneity, and conformity. The dynamic jaw mode provided better sparing of organs at risks with minimal disturbance of dose–volume indices of PTV. Considering the treatment time, the 5-cm-field dynamic jaw mode is more efficient than the 2.5-cm fixed jaw mode.
Collapse
Affiliation(s)
- Chikao Sugie
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Yoshihiko Manabe
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Akihiro Hayashi
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Department of Radiology, Okazaki City Hospital, Okazaki, Japan
| | - Taro Murai
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Taiki Takaoka
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Yukiko Hattori
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Department of Radiation Oncology, Nagoya Proton Therapy Center, Nagoya, Japan
| | - Hiromitsu Iwata
- Department of Radiation Oncology, Nagoya Proton Therapy Center, Nagoya, Japan
| | - Ran Takenaka
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Department of Radiology, Narita Memorial Hospital, Toyohashi, Japan
| | - Yuta Shibamoto
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| |
Collapse
|
34
|
Zhang F, Wang Y, Xu W, Jiang H, Liu Q, Gao J, Yao B, Hou J, He H. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery. Technol Cancer Res Treat 2014; 14:515-23. [PMID: 25311257 DOI: 10.1177/1533034614551873] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2014] [Accepted: 06/06/2014] [Indexed: 12/25/2022] Open
Abstract
Intensity-modulated radiotherapy (IMRT) potentially leads to a more favorite dose distribution compared to 3-dimensional or conventional tangential radiotherapy (RT) for breast cancer after conservative surgery or mastectomy. The aim of this study was to compare dosimetric parameters of the planning target volume (PTV) and organs at risk (OARs) among helical tomotherapy (HT), inverse-planned IMRT (IP-IMRT), and forward-planned field in field (FP-FIF) IMRT techniques after breast-conserving surgery. Computed tomography scans from 20 patients (12 left sided and 8 right sided) previously treated with T1N0 carcinoma were selected for this dosimetric planning study. We designed HT, IP-IMRT, and FP-FIF plans for each patient. Plans were compared according to dose-volume histogram analysis in terms of PTV homogeneity and conformity indices (HI and CI) as well as OARs dose and volume parameters. Both HI and CI of the PTV showed statistically significant difference among IP-IMRT, FP-FIF, and HT with those of HT were best (P < .05). Compared to FP-FIF, IP-IMRT showed smaller exposed volumes of ipsilateral lung, heart, contralateral lung, and breast, while HT indicated smaller exposed volumes of ipsilateral lung but larger exposed volumes of contralateral lung and breast as well as heart. In addition, HT demonstrated an increase in exposed volume of ipsilateral lung (except for fraction of lung volume receiving >30 Gy and 20 Gy), heart, contralateral lung, and breast compared with IP-IMRT. For breast cancer radiotherapy (RT) after conservative surgery, HT provides better dose homogeneity and conformity of PTV compared to IP-IMRT and FP-FIF techniques, especially for patients with supraclavicular lymph nodes involved. Meanwhile, HT decreases the OAR volumes receiving higher doses with an increase in the volumes receiving low doses, which is known to lead to an increased rate of radiation-induced secondary malignancies. Hence, composite factors including dosimetric advantage, clinical effect, and economic burden should be taken into comprehensive consideration when choosing an RT technique in clinical practice.
Collapse
Affiliation(s)
- Fuli Zhang
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Yadi Wang
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Weidong Xu
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Huayong Jiang
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Qingzhi Liu
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Junmao Gao
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Bo Yao
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Jun Hou
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| | - Heliang He
- Radiation Oncology Department, The Military General Hospital of Beijing PLA, Beijing, P.R. China
| |
Collapse
|
35
|
Klüter S, Schubert K, Lissner S, Sterzing F, Oetzel D, Debus J, Schlegel W, Oelfke U, Nill S. Independent calculation of dose distributions for helical tomotherapy using a conventional treatment planning system. Med Phys 2014; 41:081709. [PMID: 25086519 DOI: 10.1118/1.4887779] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE The dosimetric verification of treatment plans in helical tomotherapy usually is carried out via verification measurements. In this study, a method for independent dose calculation of tomotherapy treatment plans is presented, that uses a conventional treatment planning system with a pencil kernel dose calculation algorithm for generation of verification dose distributions based on patient CT data. METHODS A pencil beam algorithm that directly uses measured beam data was configured for dose calculation for a tomotherapy machine. Tomotherapy treatment plans were converted into a format readable by an in-house treatment planning system by assigning each projection to one static treatment field and shifting the calculation isocenter for each field in order to account for the couch movement. The modulation of the fluence for each projection is read out of the delivery sinogram, and with the kernel-based dose calculation, this information can directly be used for dose calculation without the need for decomposition of the sinogram. The sinogram values are only corrected for leaf output and leaf latency. Using the converted treatment plans, dose was recalculated with the independent treatment planning system. Multiple treatment plans ranging from simple static fields to real patient treatment plans were calculated using the new approach and either compared to actual measurements or the 3D dose distribution calculated by the tomotherapy treatment planning system. In addition, dose-volume histograms were calculated for the patient plans. RESULTS Except for minor deviations at the maximum field size, the pencil beam dose calculation for static beams agreed with measurements in a water tank within 2%/2 mm. A mean deviation to point dose measurements in the cheese phantom of 0.89% ± 0.81% was found for unmodulated helical plans. A mean voxel-based deviation of -0.67% ± 1.11% for all voxels in the respective high dose region (dose values >80%), and a mean local voxel-based deviation of -2.41% ± 0.75% for all voxels with dose values >20% were found for 11 modulated plans in the cheese phantom. Averaged over nine patient plans, the deviations amounted to -0.14% ± 1.97% (voxels >80%) and -0.95% ± 2.27% (>20%, local deviations). For a lung case, mean voxel-based deviations of more than 4% were found, while for all other patient plans, all mean voxel-based deviations were within ± 2.4%. CONCLUSIONS The presented method is suitable for independent dose calculation for helical tomotherapy within the known limitations of the pencil beam algorithm. It can serve as verification of the primary dose calculation and thereby reduce the need for time-consuming measurements. By using the patient anatomy and generating full 3D dose data, and combined with measurements of additional machine parameters, it can substantially contribute to overall patient safety.
Collapse
Affiliation(s)
- Sebastian Klüter
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Kai Schubert
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Steffen Lissner
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Florian Sterzing
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Dieter Oetzel
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Jürgen Debus
- Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Wolfgang Schlegel
- German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
| | - Uwe Oelfke
- German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany and Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5NG, United Kingdom
| | - Simeon Nill
- Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5NG, United Kingdom
| |
Collapse
|
36
|
Michalski A, Atyeo J, Cox J, Rinks M, Morgia M, Lamoury G. A dosimetric comparison of 3D-CRT, IMRT, and static tomotherapy with an SIB for large and small breast volumes. Med Dosim 2014; 39:163-8. [DOI: 10.1016/j.meddos.2013.12.003] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2013] [Revised: 11/25/2013] [Accepted: 12/03/2013] [Indexed: 10/25/2022]
|
37
|
Takahashi Y, Verneris MR, Dusenbery K, Wilke C, Storme G, Weisdorf DJ, Hui SK. Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy. Int J Radiat Oncol Biol Phys 2013; 87:832-9. [PMID: 24011657 PMCID: PMC3805769 DOI: 10.1016/j.ijrobp.2013.07.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2013] [Revised: 07/03/2013] [Accepted: 07/15/2013] [Indexed: 10/26/2022]
Abstract
PURPOSE To report potential dose heterogeneity leading to underdosing at different skeletal sites in total marrow irradiation (TMI) with helical tomotherapy due to the thread effect and provide possible solutions to reduce this effect. METHODS AND MATERIALS Nine cases were divided into 2 groups based on patient size, defined as maximum left-to-right arm distance (mLRD): small mLRD (≤47 cm) and large mLRD (>47 cm). TMI treatment planning was conducted by varying the pitch and modulation factor while a jaw size (5 cm) was kept fixed. Ripple amplitude, defined as the peak-to-trough dose relative to the average dose due to the thread effect, and the dose-volume histogram (DVH) parameters for 9 cases with various mLRD was analyzed in different skeletal regions at off-axis (eg, bones of the arm or femur), at the central axis (eg, vertebrae), and planning target volume (PTV), defined as the entire skeleton plus 1-cm margin. RESULTS Average ripple amplitude for a pitch of 0.430, known as one of the magic pitches that reduce thread effect, was 9.2% at 20 cm off-axis. No significant differences in DVH parameters of PTV, vertebrae, or femur were observed between small and large mLRD groups for a pitch of ≤0.287. Conversely, in the bones of the arm, average differences in the volume receiving 95% and 107% dose (V95 and V107, respectively) between large and small mLRD groups were 4.2% (P=.016) and 16% (P=.016), respectively. Strong correlations were found between mLRD and ripple amplitude (rs=.965), mLRD and V95 (rs=-.742), and mLRD and V107 (rs=.870) of bones of the arm. CONCLUSIONS Thread effect significantly influences DVH parameters in the bones of the arm for large mLRD patients. By implementing a favorable pitch value and adjusting arm position, peripheral dose heterogeneity could be reduced.
Collapse
Affiliation(s)
- Yutaka Takahashi
- Masonic Cancer Center, Division of Hematology, Oncology and Bone Marrow Transplantation
| | - Michael R. Verneris
- Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation
| | | | | | - Guy Storme
- Department of Radiotherapy, Universitair Ziekenhuis Brussel
| | | | - Susanta K Hui
- Masonic Cancer Center, Division of Hematology, Oncology and Bone Marrow Transplantation
- Department of Therapeutic Radiology, University of Minnesota
| |
Collapse
|
38
|
Lissner S, Schubert K, Wiezorek T, Sterzing F, Herfarth K, Sroka-Perez G, Debus J. Investigations of peripheral dose for helical tomotherapy. Z Med Phys 2013; 23:324-31. [PMID: 23876598 DOI: 10.1016/j.zemedi.2013.06.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2012] [Revised: 02/14/2013] [Accepted: 06/14/2013] [Indexed: 11/19/2022]
Abstract
PURPOSE Whenever treating a patient with percutaneous radiotherapy, a certain amount of dose is inevitably delivered to healthy tissue. This is mainly due to beam's entry and exit in the region of the target volume. In regions distant from the target volume, dose is delivered by leakage from the MLC and head scatter from the accelerator head and phantom scatter from the target volume (peripheral dose). Helical tomotherapy is a form of radiation therapy with a uniquely designed machine and delivery pattern which influence the peripheral dose. The goal of this work was to investigate peripheral dose in helical tomotherapy. The experiments were used to establish a complex characterization of the peripheral dose. MATERIALS AND METHODS A 30*30*60cm(3) slab phantom and TLD-100 (Lithium fluoride) were used for the experiments. Treatment procedures were generated with the tomotherapy planning system (TPS). Additionally, procedures were created on the Operator Station of the tomotherapy system without a calculation of the dose distribution. The peripheral dose which was produced by a typical tomotherapy treatment plan was measured. Furthermore, these procedures were used to differentiate the parts of the peripheral dose in phantom scatter dose and head scatter and leakage dose. Additionally, the relation between peripheral dose and treatment time and between peripheral dose and delivered dose was investigated. Additionally, the peripheral dose was measured in an Alderson phantom. RESULTS Distances of 30cm or more resulted in a decrease of the peripheral dose to less than 0.1% of the target dose. The measured doses have an offset of approximately 1cGy in comparison to the calculated doses from the TPS. The separated head scatter and leakage dose was measured in the range of 1cGy for typical treatments. Furthermore, the investigations show a linear correlation between head scatter leakage dose and treatment time and between scatter dose parts and delivered dose. A peripheral dose of 0.28% of the target dose was measured in the Alderson phantom at a distance of 17.5cm from the edge of the target volume. CONCLUSIONS The peripheral dose delivered by a tomotherapy treatment is clinically unobjectionable. The measurements confirmed a linear correlation between head scatter and leakage and treatment time and between scatter dose and delivered dose.
Collapse
Affiliation(s)
- Steffen Lissner
- Department of Radiation Oncology, University Hospital Heidelberg, Germany.
| | | | | | | | | | | | | |
Collapse
|
39
|
Nalichowski A, Burmeister J. Dosimetric comparison of helical tomotherapy treatment plans for total marrow irradiation created using GPU and CPU dose calculation engines. Med Phys 2013; 40:071716. [DOI: 10.1118/1.4810936] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
|
40
|
Van Gestel D, van Vliet-Vroegindeweij C, Van den Heuvel F, Crijns W, Coelmont A, De Ost B, Holt A, Lamers E, Geussens Y, Nuyts S, Van den Weyngaert D, Van den Wyngaert T, Vermorken JB, Gregoire V. RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. Radiat Oncol 2013; 8:37. [PMID: 23425449 PMCID: PMC3599972 DOI: 10.1186/1748-717x-8-37] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2012] [Accepted: 02/06/2013] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Radiotherapy techniques have evolved rapidly over the last decade with the introduction of Intensity Modulated RadioTherapy (IMRT) in different forms. It is not clear which of the IMRT techniques is superior in the treatment of head and neck cancer patients in terms of coverage of the planning target volumes (PTVs), sparing the organs at risk (OARs), dose to the normal tissue, number of monitor units needed and delivery time.The present paper aims to compare Step and Shoot (SS) IMRT, Sliding Window (SW) IMRT, RapidArc (RA) planned with Eclipse, Elekta VMAT planned with SmartArc (SA) and helical TomoHD™ (HT). METHODS Target volumes and organs at risk (OARs) of five patients with oropharyngeal cancer were delineated on contrast enhanced CT-scans, then treatment plans were generated on five different IMRT systems. In 32 fractions, 69.12 Gy and 56 Gy were planned to the therapeutic and prophylactic PTVs, respectively. For the PTVs and 26 OARs ICRU 83 reporting guidelines were followed. Differences in the studied parameters between treatment planning systems were analysed using repeated measures ANOVA. RESULTS Mean Homogeneity Index of PTV(therapeutic) is better with HT(.06) followed by SA(.08), RA(.10), SW(.10) and SS(.11). PTV(prophylactic) is most homogeneous with RA. Parotid glands prescribed mean doses are only obtained by SA and HT, 20.6 Gy and 21.7 Gy for the contralateral and 25.6 Gy and 24.1 Gy for the ipsilateral, against 25.6 Gy and 32.0 Gy for RA, 26.4 Gy and 34.6 Gy for SW, and 28.2 Gy and 34.0 Gy for SS. RA uses the least monitor units, HT the most. Treatment times are 3.05 min for RA, and 5.9 min for SA and HT. CONCLUSIONS In the treatment of oropharyngeal cancer, we consider rotational IMRT techniques preferable to fixed gantry techniques due to faster fraction delivery and better sparing of OARs without a higher integral dose. TomoHD gives most homogeneous target coverage with more sparing of spinal cord, brainstem, parotids and the lower swallowing apparatus than most of the other systems. Between RA and SA, SA gives a more homogeneous PTV(therapeutic) while sparing the parotids more, but the delivery of RA is twice as fast with less overdose to the PTV(elective).
Collapse
Affiliation(s)
- Dirk Van Gestel
- Department of Radiotherapy, University Radiotherapy department Antwerp – UZA / ZNA, Lindendreef 1, 2020, Antwerp, Belgium
| | - Corine van Vliet-Vroegindeweij
- Department of Radiotherapy, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | | | - Wouter Crijns
- Department of Radiation Oncology, Leuvens Kankerinstituut, Leuven, Belgium
| | - Ann Coelmont
- Department of Radiotherapy, University Radiotherapy department Antwerp – UZA / ZNA, Lindendreef 1, 2020, Antwerp, Belgium
| | - Bie De Ost
- Department of Radiotherapy, University Radiotherapy department Antwerp – UZA / ZNA, Lindendreef 1, 2020, Antwerp, Belgium
| | - Andrea Holt
- Department of Radiotherapy, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | - Emmy Lamers
- Department of Radiotherapy, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | - Yasmyne Geussens
- Department of Radiation Oncology, Leuvens Kankerinstituut, Leuven, Belgium
| | - Sandra Nuyts
- Department of Radiation Oncology, Leuvens Kankerinstituut, Leuven, Belgium
| | - Danielle Van den Weyngaert
- Department of Radiotherapy, University Radiotherapy department Antwerp – UZA / ZNA, Lindendreef 1, 2020, Antwerp, Belgium
| | | | - Jan B Vermorken
- Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium
| | - Vincent Gregoire
- Radiation Oncology Department & Centre for Molecular Imaging and Experimental Radiotherapy, St-Luc University Hospital, Brussels, Belgium
| |
Collapse
|
41
|
Empirical estimation of beam-on time for prostate cancer patients treated on Tomotherapy. Rep Pract Oncol Radiother 2013; 18:201-8. [PMID: 24416554 DOI: 10.1016/j.rpor.2012.12.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2012] [Revised: 10/04/2012] [Accepted: 12/30/2012] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND AND AIM This study proposed a method to estimate the beam-on time for prostate cancer patients treated on Tomotherapy when FW (field width), PF (pitch factor), modulation factor (MF) and treatment length (TL) were given. MATERIAL AND METHODS THE STUDY WAS DIVIDED INTO TWO PARTS: building and verifying the model. To build a model, 160 treatment plans were created for 10 patients. The plans differed in combination of FW, PF and MF. For all plans a graph of beam-on time as a function of TL was created and a linear trend function was fitted. Equation for each trend line was determined and used in a correlation model. Finally, 62 plans verified the treatment time computation model - the real execution time was compared with our estimation and irradiation time calculated based on the equation provided by the manufacturer. RESULTS A linear trend function was drawn and the coefficient of determination R (2) and the Pearson correlation coefficient r were calculated for each of the 8 trend lines corresponding to the adequate treatment plan. An equation to correct the model was determined to estimate more accurately the beam-on time for different MFs. From 62 verification treatment plans, only 5 disagreed by more than 60 s with the real time from the HT software. Whereas, for the equation provided by the manufacturer the discrepancy was observed in 16 cases. CONCLUSIONS Our study showed that the model can well predict the treatment time for a given TL, MF, FW and it can be used in clinical practice.
Collapse
|
42
|
Kissick MW, Mackie TR, Flynn RT, Mo X, Campos DD, Yan Y, Zhao D. Investigation of probabilistic optimization for tomotherapy. J Appl Clin Med Phys 2012; 13:3865. [PMID: 22955654 PMCID: PMC3753820 DOI: 10.1120/jacmp.v13i5.3865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2011] [Revised: 04/25/2012] [Accepted: 04/30/2012] [Indexed: 11/23/2022] Open
Abstract
This work builds on a suite of studies related to the ‘interplay’, or lack thereof, for respiratory motion with helical tomotherapy (HT). It helps explain why HT treatments without active motion management had clinical outcomes that matched positive expectations. An analytical calculation is performed to illuminate the frequency range for which interplay‐type dose errors could occur. Then, an experiment is performed which completes a suite of tests. The experiment shows the potential for a stable motion probability distribution function (PDF) with HT and respiratory motion. This PDF enables one to use a motion‐robust or probabilistic optimization to intrinsically include respiratory motion into the treatment planning. The reason why HT is robust to respiratory motion is related to the beam modulation sampling of the tumor motion. Because active tracking‐based motion management is more complicated for a variety of reasons, HT optimization that is robust to motion is a useful alternative for those many patients that cannot benefit from active motion management. PACS number: 87.55.‐x, 87.56.‐v
Collapse
Affiliation(s)
- Michael W Kissick
- Department of Medical Physics, Wisconsin Institutes for Medical Research, University of Wisconsin – Madison, Madison, WI 53705, USA.
| | | | | | | | | | | | | |
Collapse
|
43
|
Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: an exploratory study. Radiother Oncol 2012; 105:41-8. [PMID: 22682748 DOI: 10.1016/j.radonc.2012.05.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2011] [Revised: 05/08/2012] [Accepted: 05/18/2012] [Indexed: 11/22/2022]
Abstract
PURPOSE To quantify associations between pre-radiotherapy and post-radiotherapy PET parameters via spatially resolved regression. MATERIALS AND METHODS Ten canine sinonasal cancer patients underwent PET/CT scans of [(18)F]FDG (FDG(pre)), [(18)F]FLT (FLT(pre)), and [(61)Cu]Cu-ATSM (Cu-ATSM(pre)). Following radiotherapy regimens of 50 Gy in 10 fractions, veterinary patients underwent FDG PET/CT scans at 3 months (FDG(post)). Regression of standardized uptake values in baseline FDG(pre), FLT(pre) and Cu-ATSM(pre) tumour voxels to those in FDG(post) images was performed for linear, log-linear, generalized-linear and mixed-fit linear models. Goodness-of-fit in regression coefficients was assessed by R(2). Hypothesis testing of coefficients over the patient population was performed. RESULTS Multivariate linear model fits of FDG(pre) to FDG(post) were significantly positive over the population (FDG(post) ~ 0.17 · FDG(pre), p = 0.03), and classified slopes of RECIST non-responders and responders to be different (0.37 vs. 0.07, p = 0.01). Generalized-linear model fits related FDG(pre) to FDG(post) by a linear power law (FDG(post) ~ FDG(pre)(0.93),p<0.001). Univariate mixture model fits of FDG(pre) improved R(2) from 0.17 to 0.52. Neither baseline FLT PET nor Cu-ATSM PET uptake contributed statistically significant multivariate regression coefficients. CONCLUSIONS Spatially resolved regression analysis indicates that pre-treatment FDG PET uptake is most strongly associated with three-month post-treatment FDG PET uptake in this patient population, though associations are histopathology-dependent.
Collapse
|
44
|
Myers P, Stathakis S, Gutiérrez AN, Esquivel C, Mavroidis P, Papanikolaou N. Evaluation of PTW Seven29 for tomotherapy patient-specific quality assurance and comparison with ScandiDos Delta(4). J Med Phys 2012; 37:72-80. [PMID: 22557796 PMCID: PMC3339146 DOI: 10.4103/0971-6203.94741] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2011] [Revised: 02/15/2012] [Accepted: 02/15/2012] [Indexed: 11/04/2022] Open
Abstract
For routine quality assurance of helical tomotherapy plans, an alternative method, as opposed to the TomoTherapy suggested cylindrical solid water phantom with film and ionization chamber, is proposed using the PTW Seven29 2D-ARRAY inserted in a dedicated octagonal phantom, called Octavius. First, the sensitivity of the array to pitch was studied by varying the pitch during planning to 0.287, 0.433, 1.0, and 2.0. For each pitch selected, the dependence on field size was investigated by generating plans with field widths (FWs) of 1.06 cm, 2.49 cm, and 5.02 cm, for a total of 12 plans. Secondly, a total of 15 patient QA plans were delivered using helical tomotherapy with the Delta(4) and Seven29/Octavius for comparison. Using the clinical gamma criteria, 3% and 3 mm, all FW and pitch plans had a passing percentage of >90%. For patient QA plans, the average gamma pass percentage was 97.0% (94.4-99.8%) for the Delta(4) and 97.6% (92.5-100.0%) for the Seven29/Octavius. Both the Seven29/Octavius and Delta(4) performed to a high standard of measurement accuracy and had a 90% or greater gamma percent for all plans and were considered clinically acceptable.
Collapse
Affiliation(s)
- Pamela Myers
- Department of Radiology and Radiation Oncology, Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio, 7979 Wurzbach Rd, San Antonio, USA
| | | | | | | | | | | |
Collapse
|
45
|
Skórska M, Piotrowski T. Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients. Phys Med 2012; 29:273-85. [PMID: 22521735 DOI: 10.1016/j.ejmp.2012.03.007] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2011] [Revised: 03/22/2012] [Accepted: 03/27/2012] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND AND PURPOSE Tomotherapy treatment planning depends on parameters that are not used conventionally such as: field width (FW), pitch factor (PF) and modulation factor (MF). The aim of this study is to analyze the relationship between these parameters and their influence on the quality of treatment plans and beam-on time. MATERIAL AND METHODS Ten prostate cancer patients were included in the study. For each patient, two cases of irradiation were considered depending on the target volume: PTV1 included the prostate gland, seminal vesicles, pelvic lymph nodes and a 1 cm margin, whereas PTV2 included only the prostate gland with a 1 cm margin. For each patient and each case of irradiation (PTV1 and PTV2) 8 treatment plans were created - all consisted of a different combination of planning parameters (FW = 1.05, 2.5, 5 cm; PF = 0.107, 0.215, 0.43; MF = 1.5, 2.5, 3.5). Default values used in this study were FW = 2.5 cm, PF = 0.215 and MF = 2.5. Hence, for plans with different FWs, parameters of PF and MF were 0.215 and 2.5, respectively; for different PFs, FW and MF were 2.5 and 2.5, respectively; finally for different MFs, FW and PF were 2.5 and 0.215, respectively. The reference plan was optimized for FW = 1.05 cm, PF = 0.107 and MF = 3.5, which was assumed to result in the best dose distribution and the longest treatment time. As a result, 160 plans were created. Each plan was analyzed for dose distribution and execution time. RESULTS AND CONCLUSION : Treatment plans with FW of 5 cm resulted in the shortest execution time compromising the dose distribution. Moreover, the dose fall off in the longitudinal direction was not sharp. FW of 1.05 cm and PF of 0.107 were not recommended for routine prostate plans due to long execution time, which was 3 times longer than for plans with FW = 5 cm. There was no substantial decrease of irradiation time when PF was increased from 0.215 to 0.43 for both cases (PTV1 and PTV2); however, the dose distribution was slightly compromised. Finally, decreasing MF from 2.5 to 1.5 was useless because it did not change the beam-on time; however, it did remarkably decrease the dose distribution. Nevertheless, increasing MF up to 3.5 could be considered. The lowest EUD for the rectum and intestines, could be observed for PF = 0.107. For the other plans the differences were rather small (the EUD was almost the same). By reducing PF from 0.43 to 0.107 or FW from 5 to 1.05 the EUD for bladder (in PTV1 case) decreased by 3.13% and 2.60%. When PTV2 was a target volume, the EUD for bladder decreased by 4.54% and 3.43% when FW was changed from 5 to 1.05 and MF from 1.5 to 3.5, respectively. For optimal balance between beam-on time and dose distribution in OARs for routine patients, the authors would suggest to use: FW = 2.5, PF = 0.215 and MF = 2.5.
Collapse
Affiliation(s)
- M Skórska
- Department of Medical Physics, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland.
| | | |
Collapse
|
46
|
Kainz K, White J, Chen GP, Hermand J, England M, Li XA. Simultaneous irradiation of the breast and regional lymph nodes in prone position using helical tomotherapy. Br J Radiol 2012; 85:e899-905. [PMID: 22457317 DOI: 10.1259/bjr/18685881] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVE We investigated dosimetric advantages of using helical tomotherapy to simultaneously irradiate the breast and regional lymph nodes for patients positioned prone, and compared tomotherapy plan qualities for the prone position with those previously published for the supine position. METHODS Tomotherapy plans for 11 patients (5 left breast, 6 right) simulated with the involved breast suspended downward were generated. Each target (ipsilateral breast and supraclavicular, axillary and internal mammary chain nodes) was to receive 45 Gy. RESULTS For targets, V(40.5)≥99.9% and V(42.8)≥99.5% for all patients, where V(40.5) and V(42.8) denote the relative target volume receiving at least 40.5 and 42.8 Gy, respectively. The targets' maximum dose was, on average, approximately 49.5 Gy. The mean doses to the contralateral lung and heart were lower for right-breast cases (2.8 Gy lung, 2.7 Gy heart) than for left-breast cases (3.8 Gy lung, 8.7 Gy heart). Mean organ doses to the ipsilateral lung (9.3 Gy) and contralateral breast (2.3 Gy) from the prone breast tomotherapy plans were similar to those reported for conventional radiotherapy techniques. For the left breast with regional nodes, tomotherapy plans for prone-positioned patients yielded lower mean doses to the contralateral breast and heart than previously reported data for tomotherapy plans for supine-positioned patients. CONCLUSION Helical tomotherapy with prone breast positioning can simultaneously cover the breast and regional nodes with acceptable uniformity and can provide reduced mean dose to proximal organs at risk compared with tomotherapy with supine position. The similarity of plan quality to existing data for conventional breast radiotherapy indicates that this planning approach is appropriate, and that the risk of secondary tumour formation should not be significantly greater.
Collapse
Affiliation(s)
- K Kainz
- Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
| | | | | | | | | | | |
Collapse
|
47
|
Tomotherapy - a different way of dose delivery in radiotherapy. Contemp Oncol (Pozn) 2012; 16:16-25. [PMID: 23788850 PMCID: PMC3687380 DOI: 10.5114/wo.2012.27332] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2011] [Revised: 09/21/2011] [Accepted: 01/18/2012] [Indexed: 11/17/2022] Open
Abstract
AIM OF THE STUDY Helical tomotherapy is one of the methods of radiotherapy. This method enables treatment implementation for a wide spectrum of clinical cases. The vast array of therapeutic uses of helical tomotherapy results directly from the method of dose delivery, which is significantly different from the classic method developed for conventional linear accelerators. The paper discusses the method of dose delivery by a tomotherapy machine. Moreover, an analysis and presentation of treatment plans was performed in order to show the therapeutic possibilities of the applied technology. Dose distributions were obtained for anaplastic medulloblastoma, multifocal metastases to brain, vulva cancer, tongue cancer, metastases to bones, and advanced skin cancer. Tomotherapy treatment plans were compared with conventional linear accelerator plans. RESULTS Following the comparative analysis of tomotherapy and conventional linear accelerator plans, in each case we obtained the increase in dose distribution conformity manifested in greater homogeneity of doses in the radiation target area for anaplastic medulloblastoma, multifocal metastases to brain, vulva cancer, metastases to bones, and advanced skin cancer, and the reduction of doses in organs at risk (OAR) for anaplastic medulloblastoma, vulva cancer, tongue cancer, and advanced skin cancer. The time of treatment delivery in the case of a tomotherapy machine is comparable to the implementation of the plan prepared in intensity-modulated radiotherapy (IMRT) technique for a conventional linear accelerator. In the case of tomotherapy the application of a fractional dose was carried out in each case during one working period of the machine. For a conventional linear accelerator the total value of the fractional dose in the case of anaplastic medulloblastoma and metastases to bones was delivered using several treatment plans, for which a change of set-up was necessary during a fraction. CONCLUSION The obtained results confirm that tomotherapy offers the possibility to obtain precise treatment plans together with the simplification of the therapeutic system.
Collapse
|
48
|
Sheng K, Jones R, Yang W, Saraiya S, Schneider B, Chen Q, Sobering G, Olivera G, Read P. 3D Dose Verification Using Tomotherapy CT Detector Array. Int J Radiat Oncol Biol Phys 2012; 82:1013-20. [DOI: 10.1016/j.ijrobp.2010.12.043] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2010] [Revised: 12/22/2010] [Accepted: 12/29/2010] [Indexed: 11/26/2022]
|
49
|
Chen M, Chen Y, Chen Q, Lu W. Theoretical analysis of the thread effect in helical TomoTherapy. Med Phys 2012; 38:5945-60. [PMID: 22047359 DOI: 10.1118/1.3644842] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE The longitudinal dose ripple on the off-axis caused by helical radiation delivery, such as the TomoTherapy system, has been observed, and its relation with respect to pitch has been studied with empirically found optimal pitches, 0.86∕n, by Kissick et al. [Med. Phys. 32, 1414-1423 (2005)]. This ripple artifact referred to as the thread effect is periodic in nature and is caused by various periodic factors. In this work, the factors that cause the thread effect were unveiled, including jaw profile divergence, the inverse square law, attenuation, and the cone effect, and their impact on the thread effect were studied. METHODS Mathematical formulation for individual and combined factors were set up. Based on theoretical analysis and simulations, optimal pitches that result in local minima of the ripple amplitude with respect to the jaw width and off-axis distance were identified and verified. The effectiveness of optimization in reducing the thread effect were also studied. RESULTS Analysis and simulation based on the square-shaped jaw profiles well characterize the thread effect. Simulations based on the real jaw profiles show reduced ripples and very good agreement of optimal pitches compared with those based on the square profiles. The optimal pitches were found to have little jaw width dependence, except for the real jaw profile of small width (1.05 cm). The optimal pitches for the real jaw profile of width 1.05 cm are unidentifiable except for the largest ones, due to the relative smoothness of the jaw profile. With optimized intensity modulation, the thread effect can be largely suppressed. For real jaw profiles, the optimal pitches with or without dose optimization do not change much. The numbers 0.86∕n found by Kissick et al. well approximate the optimal pitches for off-axis distance of 5 cm. However, optimal pitches are not universal for different off-axis distances: they decrease as the off-axis distance increases. CONCLUSIONS The thread effect can be well explained by the proposed model. Optimization can largely reduce the thread effect. However, an optimal pitch reduces the ripple much easier especially when optimization is limited by many constraints. The optimal pitches predicted by the proposed model could be used as a reference for pitch selection regardless the tumor is at large or small off-axis distance.
Collapse
|
50
|
Shimizu H, Tachibana H, Kubota T, Imamura H, Matsushima S, Yoshimoto M, Kodaira T. [Investigation for decrease of delivery time for the prostate cancer patient by modifications of treatment planning parameters in TomoTherapy planning station]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2011; 67:1548-58. [PMID: 22186200 DOI: 10.6009/jjrt.67.1548] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The purpose of present study is to investigate the decrease of delivery time for prostate cancer patient by using the helical type accelerator, Hi-Art System. The delivery time for Hi-Art System depends on planning parameters [pitch, modulation factor (MF) and field width (FW)], which are set by the operator at the beginning of the treatment planning. If you can allow for the deterioration of the dose distribution, the delivery time is able to decrease by increasing of FW and/or by decreasing of MF. On the other hands, as the use of 5.0 cm FW tends to increase the dose for the penile bulb, enough consideration for the dose distribution is needed. In addition, pitch should be set for the gantry rotation period not to become 15 s or less to prevent the increase of delivery time.
Collapse
Affiliation(s)
- Hidetoshi Shimizu
- Department of Therapeutic Radiation Oncology, Aichi Cancer Center Hospital
| | | | | | | | | | | | | |
Collapse
|